• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Caduet (amlodipine besylate/atorvastatin calcium) tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- July 2009

 

Summary View

 

ADVERSE REACTIONS

The Atorvastatin Component of CADUET/Postintroduction Reports with Atorvastatin
  • hepatic failure